Corporate
Protara's TARA-002 Posts 68% Response Rate in Bladder Cancer, Stock Jumps 8%
4d ago
You're signed outSign in or to get full access.
PT
Protara Therapeutics (TARA)·Earnings Reports
Q3 2025
View earnings summary and analysis
Q2 2025
View earnings summary and analysis
Q1 2025
View earnings summary and analysis
Q4 2024
View earnings summary and analysis
Research analysts covering Protara Therapeutics.